“Outliers are what you’re going…
“Outliers are what you’re going for,” Model Medicines CEO Daniel [...]
“Outliers are what you’re going for,” Model Medicines CEO Daniel [...]
A federal appeals court ruling against the Food and Drug [...]
Andrea Pfeifer, Ph.D., the longtime leader of Swiss neurodegeneration outfit [...]
Eli Lilly has made a six-year, $50 million commitment to [...]
Following an FDA approval in muscle-invasive bladder cancer patients who [...]
As the wave of in vivo CAR-T hype crests, Create [...]
A phase 2 trial of Biogen and Ionis Pharmaceuticals’ tau-targeting [...]
Regenxbio’s gene therapy for Duchenne muscular dystrophy has smashed the [...]
Aptose Biosciences has scrapped a deal for a blood cancer [...]
The Purdue Pharma case is closed, but the opioid problem [...]